Orexo AB Financials
| ORX Stock | SEK 12.28 1.92 18.53% |
Orexo |
Understanding current and past Orexo AB Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Orexo AB's financial statements are interrelated, with each one affecting the others. For example, an increase in Orexo AB's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Orexo AB's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Orexo AB. Check Orexo AB's Beneish M Score to see the likelihood of Orexo AB's management manipulating its earnings.
Orexo AB Stock Summary
Orexo AB competes with Swedish Orphan, BioInvent International, Camurus AB, BioArctic, and Active Biotech. Orexo AB , a specialty pharmaceutical company, develops products based on proprietary drug delivery technology. Orexo AB was founded in 1995 and is headquartered in Uppsala, Sweden. Orexo AB operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 130 people.| Foreign Associate | USA |
| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0000736415 |
| Business Address | PO Box 303, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.orexo.com |
| Phone | 46 1 87 80 88 00 |
| Currency | SEK - Swedish Kronor |
You should never invest in Orexo AB without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Orexo Stock, because this is throwing your money away. Analyzing the key information contained in Orexo AB's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Orexo AB Key Financial Ratios
Orexo AB's financial ratios allow both analysts and investors to convert raw data from Orexo AB's financial statements into concise, actionable information that can be used to evaluate the performance of Orexo AB over time and compare it to other companies across industries.| Return On Equity | -0.65 | |||
| Return On Asset | -0.0965 | |||
| Target Price | 38.0 | |||
| Number Of Employees | 126 | |||
| Beta | 0.72 |
Orexo Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Orexo AB's current stock value. Our valuation model uses many indicators to compare Orexo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orexo AB competition to find correlations between indicators driving Orexo AB's intrinsic value. More Info.Orexo AB is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orexo AB's earnings, one of the primary drivers of an investment's value.Orexo AB Systematic Risk
Orexo AB's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Orexo AB volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Orexo AB correlated with the market. If Beta is less than 0 Orexo AB generally moves in the opposite direction as compared to the market. If Orexo AB Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Orexo AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Orexo AB is generally in the same direction as the market. If Beta > 1 Orexo AB moves generally in the same direction as, but more than the movement of the benchmark.
Orexo AB November 26, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Orexo AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orexo AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orexo AB based on widely used predictive technical indicators. In general, we focus on analyzing Orexo Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orexo AB's daily price indicators and compare them against related drivers.
| Information Ratio | (0.28) | |||
| Maximum Drawdown | 18.7 | |||
| Value At Risk | (4.45) | |||
| Potential Upside | 2.16 |
Additional Tools for Orexo Stock Analysis
When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.